免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / EMST and Swallowing in Long-Term Survivors of HNCA

EMST and Swallowing in Long-Term Survivors of HNCA

Study Description
Brief Summary:
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on oral intake, swallowing function, and swallow-related quality of life in persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously.

Condition or disease Intervention/treatment Phase
Head and Neck Neoplasms Deglutition Disorders Behavioral: Expiratory Muscle Strength Training Behavioral: Pharyngeal Muscle Strengthening Exercises Not Applicable

Detailed Description:

Twenty (20) persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously will be randomized to an 8-week program of either EMST only and Standard Care only in order to examine the impact of EMST on swallowing function. The EMST program will consist of 5 sets of 5 breaths, 5 days per week for 8 weeks at 75% of maximum expiratory strength. Patients randomized to the EMST group will use the EMST150 (product name) expiratory muscle strength trainer according to package instructions. Standard Care will include swallowing exercises designed to strengthen muscles that contribute to pharyngeal phase motor events and increase structural range of motion. Subjects will be instructed to practice these exercises following a progressive protocol 5 days per week for 8 weeks.

All subjects will be evaluated at baseline and at the completion of their rehabilitation program. Assessment will include measurement of maximum expiratory pressure (MEP), a videofluoroscopic swallow study (VFSS) to objectively document swallow function, administration of swallow-related quality of life (QOL) questionnaires, and documentation of current diet using the International Dysphagia Diet Standardisation Initiative (IDDSI) Drink Levels and Food Levels.

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Subjects will be randomized to an 8-week program of either Expiratory Muscle Strength Training (EMST) or Standard Care in order to examine the impact of EMST on swallowing function
Masking: Single (Outcomes Assessor)
Masking Description: Researchers assessing the outcomes will not know the arm to which the subject was randomized.
Primary Purpose: Supportive Care
Official Title: Effects of Expiratory Muscle Strength Training (EMST) on Long-Term Swallowing Dysfunction in Persons With Head and Neck Cancer (HNCA) Post Irradiation (RT)
Actual Study Start Date : September 10, 2018
Estimated Primary Completion Date : October 1, 2023
Estimated Study Completion Date : October 1, 2023
Arms and Interventions
Arm Intervention/treatment
Experimental: Expiratory Muscle Strength Training
Patients randomized to the EMST arm will use the EMST150 device as packaged, i.e. following package instructions
Behavioral: Expiratory Muscle Strength Training
8 weeks of EMST at 75% maximum expiratory pressure (MEP)

Active Comparator: Pharyngeal Muscle Strengthening Exercises
Patients randomized to Standard Care will receive swallowing exercises designed to strengthen muscles that contribute to pharyngeal phase motor events and increase structural range of motion
Behavioral: Pharyngeal Muscle Strengthening Exercises
8 weeks of exercises designed to increase pharyngeal muscle strength for swallowing

Outcome Measures
Primary Outcome Measures :
  1. Level of Oral Intake (number) [ Time Frame: 8 weeks ]

    Change in Food Level and Drink Level on International Dysphagia Diet Standardisation Initiative (IDDSI) scale will be calculated from baseline to post-treatment.

    IDDSI scale rates the level of liquid or food that the person can eat. Scale values range from 0 to 7, with higher values indicating better outcome (greater ability to eat).


  2. Maximum Expiratory Pressure (MEP) cm H20 [ Time Frame: 8 weeks ]
    Change in maximum expiratory pressure level will be calculated from baseline to post-treatment.

  3. Extent of hyoid movement (mm) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the change in extent of hyoid movement in mm will be determined from baseline to post-treatment.

  4. Upper esophageal sphincter (UES) opening width (mm) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the change in width of UES opening width in mm will be determined from baseline to post-treatment.

  5. Presence of pharyngeal residue (dichotomous) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the presence of residue in the pharynx (yes or no) will be determined from baseline to post-treatment.

  6. Penetration-Aspiration Scale rating (number) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), change in the Penetration-Aspiration Scale (PAS) score will be determined from baseline to post-treatment. Penetration-Aspiration Scale is an 8-point ordinal rating scale that rates the depth to which food or liquid invades the airway. Values range from a minimum of 1 to a maximum of 8; higher values represent worse outcome (i.e. greater depth of invasion into the airway)

  7. Timing of Aspiration (category) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), timing of aspiration will be determined from baseline to post-treatment. Timing is identified as a category, either before, during, or after.


Other Outcome Measures:
  1. Eating Assessment Tool (EAT-10) (number) [ Time Frame: 8 weeks ]
    Change in score on the EAT-10 will be calculated from baseline to mid-treatment to post-treatment. EAT-10 is an ordinal rating scale with values that range from 0 to 40, with lower score reflecting better function.

  2. M.D. Anderson Dysphagia Inventory (MDADI) (number) [ Time Frame: 8 weeks ]
    Change in scores on the M.D. Anderson Dysphagia Inventory (MDADI) will be calculated from baseline to post-treatment. MDADI consists of four ordinal rating scales with scores ranging from 0 to 100 with higher score reflecting better function.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Subject was treated for cancer in the oral cavity, oropharynx, hypopharynx, larynx, or for an unknown primary at least 5 years prior to enrollment. Subjects may have had surgery as long as a minimum dose of 50 Gy of radiation was part of the treatment;
  2. Subject must have a current swallow complaint or impairment; these include but are not limited to reduced oral intake, perceived difficulty with bolus transport (e.g. feeling of food sticking in throat); aspiration on various bolus consistencies;
  3. Ability to follow directions and engage in a program of rehabilitation

Exclusion Criteria:

  1. the subject's swallowing problems are unrelated to treatment for HNCA (e.g. cognitive impairment, history of stroke);
  2. the subject presents with contraindications for EMST as specified in the EMST150 package insert unless cleared for participation by the subject's physician. These conditions include untreated hypertension, untreated gastroesophageal reflux diseas, recent stroke, lung disease, and pregnancy.
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Barbara Pauloski, Ph.D. 4142296719 pauloski@uwm.edu
Contact: Stephanie Stevens, M.S.

Locations
Layout table for location information
United States, Wisconsin
University of Wisconsin Milwaukee Active, not recruiting
Milwaukee, Wisconsin, United States, 53211
Froedtert Hospital Recruiting
Milwaukee, Wisconsin, United States, 53226
Contact: Stephanie Stevens, MS         
Sponsors and Collaborators
University of Wisconsin, Milwaukee
Froedtert Hospital
Medical College of Wisconsin
Investigators
Layout table for investigator information
Principal Investigator: Barbara Pauloski, Ph.D. University of Wisconsin, Milwaukee
Tracking Information
First Submitted Date  ICMJE June 1, 2019
First Posted Date  ICMJE June 5, 2019
Last Update Posted Date November 12, 2020
Actual Study Start Date  ICMJE September 10, 2018
Estimated Primary Completion Date October 1, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: June 4, 2019)
  • Level of Oral Intake (number) [ Time Frame: 8 weeks ]
    Change in Food Level and Drink Level on International Dysphagia Diet Standardisation Initiative (IDDSI) scale will be calculated from baseline to post-treatment. IDDSI scale rates the level of liquid or food that the person can eat. Scale values range from 0 to 7, with higher values indicating better outcome (greater ability to eat).
  • Maximum Expiratory Pressure (MEP) cm H20 [ Time Frame: 8 weeks ]
    Change in maximum expiratory pressure level will be calculated from baseline to post-treatment.
  • Extent of hyoid movement (mm) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the change in extent of hyoid movement in mm will be determined from baseline to post-treatment.
  • Upper esophageal sphincter (UES) opening width (mm) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the change in width of UES opening width in mm will be determined from baseline to post-treatment.
  • Presence of pharyngeal residue (dichotomous) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the presence of residue in the pharynx (yes or no) will be determined from baseline to post-treatment.
  • Penetration-Aspiration Scale rating (number) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), change in the Penetration-Aspiration Scale (PAS) score will be determined from baseline to post-treatment. Penetration-Aspiration Scale is an 8-point ordinal rating scale that rates the depth to which food or liquid invades the airway. Values range from a minimum of 1 to a maximum of 8; higher values represent worse outcome (i.e. greater depth of invasion into the airway)
  • Timing of Aspiration (category) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), timing of aspiration will be determined from baseline to post-treatment. Timing is identified as a category, either before, during, or after.
Original Primary Outcome Measures  ICMJE
 (submitted: June 1, 2019)
  • Level of Oral Intake (number) [ Time Frame: 8 weeks ]
    Change in Food Level and Drink Level on International Dysphagia Diet Standardisation Initiative (IDDSI) scale will be calculated from baseline to post-treatment.
  • Maximum Expiratory Pressure (MEP) cm H20 [ Time Frame: 8 weeks ]
    Change in maximum expiratory pressure level will be calculated from baseline to post-treatment.
  • Extent of hyoid movement (mm) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the change in extent of hyoid movement in mm will be determined from baseline to post-treatment.
  • Upper esophageal sphincter (UES) opening width (mm) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the change in width of UES opening width in mm will be determined from baseline to post-treatment.
  • Presence of pharyngeal residue (dichotomous) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), the presence of residue in the pharynx (yes or no) will be determined from baseline to post-treatment.
  • Penetration-Aspiration Scale rating (number) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), change in Penetration-Aspiration scale score will be determined from baseline to post-treatment. Penetration-Aspiration Scale is an 8-point ordinal rating scale.
  • Timing of Aspiration (category) [ Time Frame: 8 weeks ]
    From Videofluoroscopic Swallow Studies (VFSS), timing of aspiration will be determined from baseline to post-treatment. Timing is identified as a category, either before, during, or after.
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures
 (submitted: June 1, 2019)
  • Eating Assessment Tool (EAT-10) (number) [ Time Frame: 8 weeks ]
    Change in score on the EAT-10 will be calculated from baseline to mid-treatment to post-treatment. EAT-10 is an ordinal rating scale with values that range from 0 to 40, with lower score reflecting better function.
  • M.D. Anderson Dysphagia Inventory (MDADI) (number) [ Time Frame: 8 weeks ]
    Change in scores on the M.D. Anderson Dysphagia Inventory (MDADI) will be calculated from baseline to post-treatment. MDADI consists of four ordinal rating scales with scores ranging from 0 to 100 with higher score reflecting better function.
Original Other Pre-specified Outcome Measures Same as current
 
Descriptive Information
Brief Title  ICMJE EMST and Swallowing in Long-Term Survivors of HNCA
Official Title  ICMJE Effects of Expiratory Muscle Strength Training (EMST) on Long-Term Swallowing Dysfunction in Persons With Head and Neck Cancer (HNCA) Post Irradiation (RT)
Brief Summary This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on oral intake, swallowing function, and swallow-related quality of life in persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously.
Detailed Description

Twenty (20) persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously will be randomized to an 8-week program of either EMST only and Standard Care only in order to examine the impact of EMST on swallowing function. The EMST program will consist of 5 sets of 5 breaths, 5 days per week for 8 weeks at 75% of maximum expiratory strength. Patients randomized to the EMST group will use the EMST150 (product name) expiratory muscle strength trainer according to package instructions. Standard Care will include swallowing exercises designed to strengthen muscles that contribute to pharyngeal phase motor events and increase structural range of motion. Subjects will be instructed to practice these exercises following a progressive protocol 5 days per week for 8 weeks.

All subjects will be evaluated at baseline and at the completion of their rehabilitation program. Assessment will include measurement of maximum expiratory pressure (MEP), a videofluoroscopic swallow study (VFSS) to objectively document swallow function, administration of swallow-related quality of life (QOL) questionnaires, and documentation of current diet using the International Dysphagia Diet Standardisation Initiative (IDDSI) Drink Levels and Food Levels.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Subjects will be randomized to an 8-week program of either Expiratory Muscle Strength Training (EMST) or Standard Care in order to examine the impact of EMST on swallowing function
Masking: Single (Outcomes Assessor)
Masking Description:
Researchers assessing the outcomes will not know the arm to which the subject was randomized.
Primary Purpose: Supportive Care
Condition  ICMJE
  • Head and Neck Neoplasms
  • Deglutition Disorders
Intervention  ICMJE
  • Behavioral: Expiratory Muscle Strength Training
    8 weeks of EMST at 75% maximum expiratory pressure (MEP)
  • Behavioral: Pharyngeal Muscle Strengthening Exercises
    8 weeks of exercises designed to increase pharyngeal muscle strength for swallowing
Study Arms  ICMJE
  • Experimental: Expiratory Muscle Strength Training
    Patients randomized to the EMST arm will use the EMST150 device as packaged, i.e. following package instructions
    Intervention: Behavioral: Expiratory Muscle Strength Training
  • Active Comparator: Pharyngeal Muscle Strengthening Exercises
    Patients randomized to Standard Care will receive swallowing exercises designed to strengthen muscles that contribute to pharyngeal phase motor events and increase structural range of motion
    Intervention: Behavioral: Pharyngeal Muscle Strengthening Exercises
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: June 1, 2019)
20
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE October 1, 2023
Estimated Primary Completion Date October 1, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  1. Subject was treated for cancer in the oral cavity, oropharynx, hypopharynx, larynx, or for an unknown primary at least 5 years prior to enrollment. Subjects may have had surgery as long as a minimum dose of 50 Gy of radiation was part of the treatment;
  2. Subject must have a current swallow complaint or impairment; these include but are not limited to reduced oral intake, perceived difficulty with bolus transport (e.g. feeling of food sticking in throat); aspiration on various bolus consistencies;
  3. Ability to follow directions and engage in a program of rehabilitation

Exclusion Criteria:

  1. the subject's swallowing problems are unrelated to treatment for HNCA (e.g. cognitive impairment, history of stroke);
  2. the subject presents with contraindications for EMST as specified in the EMST150 package insert unless cleared for participation by the subject's physician. These conditions include untreated hypertension, untreated gastroesophageal reflux diseas, recent stroke, lung disease, and pregnancy.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Barbara Pauloski, Ph.D. 4142296719 pauloski@uwm.edu
Contact: Stephanie Stevens, M.S.
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03975465
Other Study ID Numbers  ICMJE PRO32538
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Barbara Pauloski, University of Wisconsin, Milwaukee
Study Sponsor  ICMJE University of Wisconsin, Milwaukee
Collaborators  ICMJE
  • Froedtert Hospital
  • Medical College of Wisconsin
Investigators  ICMJE
Principal Investigator: Barbara Pauloski, Ph.D. University of Wisconsin, Milwaukee
PRS Account University of Wisconsin, Milwaukee
Verification Date November 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP